Candida albicans, a major human fungal pathogen associated with high mortality and/or
morbidity rates in a wide variety of immunocompromised individuals, undergoes a reversible …

Azoles are commonly used for the treatment of fungal infections, and the ability of human
fungal pathogens to rapidly respond to azole treatment is critical for the development of …

The human commensal and opportunistic fungal pathogen Candida albicans displays
extensive genetic and phenotypic variation across clinical isolates. Here, we performed RNA …

Candida albicans is a major human fungal pathogen responsible for both systemic and
mucosal infections in a wide variety of immunocompromised individuals. Because the ability …

Candida albicans, the major human fungal pathogen, undergoes a reversible morphological
transition from blastospores (round budding cells) to filaments (elongated cells attached end …

Candida albicans is the most frequently encountered human fungal pathogen, causing both
superficial infections and life-threatening systemic diseases. Functional genomic studies …

Candida albicans is a leading cause of mycotic infection. The ability to transition between
yeast and filamentous forms is critical to C. albicans virulence and complex signaling …

Systemic, life-threatening infections in humans are often caused by bacterial or fungal
species that normally inhabit a different locale in our body, particularly mucosal surfaces. A …

Candida albicans, the most common cause of human fungal infections, undergoes a
reversible morphological transition from yeast to pseudohyphal and hyphal filaments, which …

Grf10, a homeodomain-containing transcription factor, regulates adenylate and one-carbon
metabolism and morphogenesis in the human fungal pathogen Candida albicans. Here, we …